Navigation Links
Translational Regenerative Medicine Forum sets stage for accelerating therapies to patients
Date:2/1/2010

Winston-Salem, N.C. -- The Regenerative Medicine Foundation today announced the first annual Translational Regenerative Medicine Forum to be held April 6-8, 2010 at the Benton Convention Center in Winston-Salem.

The forum seeks to advance the field of regenerative medicine and health care innovation through the sharing of scientific discoveries, clinical and corporate best practices and business models. Reflecting the global scope of regenerative medicine, the meeting will feature keynote speakers and panelists providing a domestic and international perspective, including critical areas such as clinical advances, trial design, venture funding and obtaining regulatory approval.

"The Translational Regenerative Medicine Forum is designed to be the premiere international event for leaders in regenerative medicine translation, representing academic and clinical research, health care policy, venture investment and biotechnology industry interests," said Anthony Atala, M.D., director, Wake Forest Institute for Regenerative Medicine, and a forum speaker. "The body's natural capacity for healing has been known for generations, and the field of regenerative medicine exists to harness this natural healing process. It takes a collaborative approach to address the challenges of delivering regenerative medicine therapies to patients in a timely and cost-effective manner, and it is our expectation that this forum will bring together all the elements and fulfill the promise of the research."

Keynote speakers and plenary panelists include Steven Bauer, Ph.D., chief of the Cell and Tissue Therapy Branch, FDA Center for Biologics Evaluation and Research; Richard Caruso, Ph.D., founder and chairman of the board, Integra; Juan Enriquez, managing director, Excel Venture Management; Robert Klein, chairman, California Institute for Regenerative Medicine; Robert Lanza, M.D., chief scientific officer, Advanced Cell Technology; Lesa Mitchell, vice president, Kauffman Foundation; Sherrill Neff, founding partner, Quaker BioVentures; and Teruo Okano, Ph.D., professor and director of the Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University.

Also, Buddy Ratner, Ph.D., professor of bioengineering and chemical engineering, University of Washington; and Camillo Ricordi, M.D., Diabetes Research Institute, University of Miami Miller School of Medicine; Lt. Gen. Eric Schoomaker, M.D., Ph.D., surgeon general/commander, U.S. Army Medical Command; Andrew von Eschenbach, M.D., former U.S. Food and Drug Administration Commissioner who is now senior advisor with Greenleaf Health and the Center for Health Transformation; John Walker, CEO, iPierian; and Jay Watkins, managing director, DeNovo Ventures.

Translational Forum attendees will include executives from biotechnology, pharmaceutical and medical device, and regenerative medicine companies, patient advocacy groups and medical research foundations as well as institutional investors from private equity and venture capital firms. The forum will also be beneficial for academic researchers, clinical researchers and physicians, and those interested in health care innovation and personalized medicine.

To foster interaction between investors and entrepreneurs, the forum will showcase 15 regenerative medicine companies presenting in front of an audience of venture capitalists and corporate venture executives. A full-day media academy precedes the forum, in order to educate reporters and editors on the basics of regenerative medicine (stem cells sources, technologies, biomaterials) and pathways to deliver new therapies to patients.


'/>"/>

Contact: Karen Richardson
krchrdsn@wfubmc.edu
336-716-4453
Wake Forest University Baptist Medical Center
Source:Eurekalert

Related medicine news :

1. Social Network for Translational Scientists Launched
2. ARVO Foundation and Pfizer Ophthalmics honor Carl B. Camras with translational research award
3. Experts Outline Challenges to Translational Research in the United States at a Capitol Hill Briefing, Emphasizing the Importance of Bringing Medical Innovation from Bench to Bedside
4. Translational Research: From Bench to Bedside Capitol Hill Breakfast Briefing Hosted by the Council for American Medical Innovation
5. ASH and EHA Jointly Announce Translational Research Training in Hematology Program
6. ASH and EHA jointly announce translational research training in hematology program
7. EAU Research Foundation organizes meeting in Amsterdam highlighting translational research results
8. Crescendo(tm), the Clinical and Translational Research Exchange, is Launched
9. Van Andel Research Institute of Michigan and Translational Genomics Research Institute of Arizona Undertake Unprecedented Alliance to Promote Science and Health
10. OnCore System Supporting Research Informatics Needs of the University of Wisconsin's Institute for Clinical and Translational Research
11. Rockefeller Universitys Center for Clinical and Translational Science funds 18 new pilot studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... ... ... Butler Mobility invited Ken Matthews to visit its manufacturing facility and showroom ... impressed with the safety and reliability of the Stannah Stairlift as well as with ... endorsement by Ken Matthews can be heard on News Radio WHP 580 weekdays from ...
(Date:2/17/2017)... , ... February 17, 2017 , ... Smiles by Seese ... Center in Davidson, NC. Dr. Brian Seese leads the practice as a skilled and ... under one roof. Smiles by Seese serves patients of all ages with excellence in ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... Feb. 22, 2017 — 1:30 p.m. – 2:30 p.m. ET, http://www.fdanews.com/deviceapproval ... asking before selecting an FDA approval pathway? , How should they evaluate ...
(Date:2/17/2017)... ... February 17, 2017 , ... Program will ... Trinity Health and the U.S. Soccer Foundation announced today that they have awarded ... Soccer for Success, the Foundation’s soccer mentoring program, teaches kids the fundamentals of ...
(Date:2/17/2017)... ... ... Like most hospitals across the nation, Onslow Memorial Hospital is looking for ... Reduction Program (HRRP), the return of a patient to the hospital within 30 days ... many providers are struggling to leverage limited resources and technology, Onslow Memorial Hospital has ...
Breaking Medicine News(10 mins):
(Date:2/18/2017)... 17, 2017   Parker Waichman LLP, ... rights of victims injured by medical devices, comments ... call for better reporting. Congress required hospitals to ... concerns involving power morcellators and duodenoscopes prompted the ... how hospitals report injuries and deaths related to ...
(Date:2/17/2017)... CINCINNATI , Feb. 17, 2017  Ethicon, ... Torax Medical, Inc., a privately held medical device ... Reflux Management System, a novel minimally invasive ... acquisition of Torax Medical will enable Ethicon to ... the anatomy-altering laparoscopic Nissen fundoplication surgical procedure. 1 ...
(Date:2/17/2017)... (NYSE, TASE: PRGO) today announced it has received final approval ... and homatropine methylbromide oral solution (syrup), 5 mg/1.5 mg per ... oral solution (syrup), 5 mg/1.5 mg per 5 mL is ... children 6 years of age and older. Annual sales for ...   ...
Breaking Medicine Technology: